Mereo BioPharma Group plc Quarterly Assets in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Mereo BioPharma Group plc quarterly Assets history and growth rate from Q4 2022 to Q3 2024.
Mereo BioPharma Group plc Assets for the quarter ending September 30, 2024 was $88.7M.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$88.7M			Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$96.1M			Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$55.9M			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$66.5M	-$10.9M	-14.1%	Dec 31, 2023	10-Q	2024-11-12
Q4 2022	$77.4M			Dec 31, 2022	10-K	2024-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.